Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu
  • quotes

  • charts

  • technicals

  • company

Medical Marijuana I (MJNA) OTHER OTC

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1289 +32.66%
on 12/19/16
0.2150 -20.47%
on 01/03/17
+0.0428 (+33.39%)
since 12/16/16
3-Month
0.0706 +142.21%
on 11/11/16
0.2680 -36.19%
on 11/03/16
+0.0890 (+108.54%)
since 10/18/16
52-Week
0.0290 +489.66%
on 02/01/16
0.2680 -36.19%
on 11/03/16
+0.1340 (+362.16%)
since 01/15/16

Most Recent Stories

More News
Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech)...

Medical Marijuana Secures Partnership with Key Pharmaceutical Distributor -- CFN Media

SEATTLE, WA--(Marketwired - Jan 18, 2017) -  CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Medical...

Medical Marijuana Secures Partnership with Key Pharmaceutical Distributor -- CFN Media

SEATTLE, WA--(Marketwired - Jan 18, 2017) -  CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Medical...

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia

Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding an exclusive Red Carpet...

Recent Recreational and Legal Marijuana Expansions Boost Cannabis Related Travel Experiences

PALM BEACH, Florida, January 10, 2017 /PRNewswire/ --

Recent Recreational and Legal Marijuana Expansions Boost Cannabis Related Travel Experiences

Cannabis companies are capitalizing on the overwhelming growth and demand throughout the industry, creating unique services and products that are producing significant revenue streams. One of the fastest...

Medical Marijuna, Inc. Investment AXIM(R) Biotech Receives Positive PK Data Results for CanChew Plus(R) CBD Gum

AXIM Biotechnologies Announces Positive Pharmacokinetic (PK) Data Results on Proprietary Delivery Method for Cannabinoids in Chewing Gum

Article Names Medical Marijuana, Inc. and AXIM(R) Biotech as Two of "10 Largest Marijuana Companies Raking in Huge Profits"

SAN DIEGO, CA--(Marketwired - January 06, 2017) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, today announced that the Company was featured...

Article Names Medical Marijuana, Inc. and AXIM(R) Biotech as Two of "10 Largest Marijuana Companies Raking in Huge Profits"

SAN DIEGO, CA--(Marketwired - January 06, 2017) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, today announced that the Company was featured...

Medical Marijuana, Inc. Subsidiary, HempMeds(R) Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR

Partnership to Provide Expanded Accessibility to RSHO(TM), the First-Ever Product Approved for Import by Brazilian Government

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Support & Resistance

2nd Resistance Point 0.1849
1st Resistance Point 0.1780
Last Price 0.1720
1st Support Level 0.1671
2nd Support Level 0.1631

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.